Form 4: H.B. Fuller Co. Executive Campe Reports Stock and Derivative Transactions
SEC Form 4 Filing
Heather Campe, Sr. VP of International Growth at H.B. Fuller Co., reports acquisition of phantom units and adjustments to stock and option holdings.
Summary
- Heather Campe, a Senior Vice President at H.B. Fuller Co., filed a Form 4 detailing changes in her beneficial ownership of company stock and derivative securities.
- The report includes the acquisition of 26.42 phantom units on March 15, 2024, which convert into common stock.
- Campe also holds various employee stock options with different exercise prices and expiration dates, as well as restricted stock units that convert into common stock.
- The report indicates that some stock options vest in annual installments, while others are fully vested.
- The reported transactions include adjustments to holdings due to dividend reinvestment and dividend equivalent features.
Sentiment
Score: 5
Explanation: This is a neutral regulatory filing. It doesn't inherently indicate positive or negative sentiment, but rather reports transactions.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Executive compensation packages often include a mix of salary, stock options, and restricted stock units to align management's interests with those of shareholders.
- The vesting schedules and exercise prices of the options are typical for executive compensation plans in publicly traded companies.
- Companies like Sherwin-Williams and RPM International, which also operate in the specialty chemicals sector, use similar equity-based compensation strategies.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive compensation and stock ownership.
- It assures stakeholders that executives' interests are aligned with those of the shareholders through equity ownership.
Key Dates
| Date | Description |
|---|---|
| 01/26/2018 | Date of employee stock option grant with an exercise price of $50.10. |
| 01/25/2019 | Date of employee stock option grant with an exercise price of $53.57. |
| 01/27/2022 | Date of employee stock option grant with an exercise price of $51.89. |
| 01/24/2023 | Date of employee stock option grant with an exercise price of $72.94 and restricted stock unit grant vesting in three annual installments. |
| 01/24/2024 | Date of employee stock option grant with an exercise price of $68.17 and restricted stock unit grant vesting in three annual installments. |
| 01/26/2025 | Date of employee stock option grant with an exercise price of $77.72 and restricted stock unit grant vesting in three annual installments. |
| 03/15/2024 | Date of transaction involving phantom units. |
| 01/24/2025 | Vesting date for restricted stock units. |
| 01/24/2026 | Vesting date for restricted stock units. |
| 01/26/2027 | Vesting date for restricted stock units and expiration date for employee stock options. |
| 01/25/2028 | Expiration date for employee stock options. |
| 01/27/2031 | Expiration date for employee stock options. |
| 01/24/2032 | Expiration date for employee stock options. |
| 01/24/2033 | Expiration date for employee stock options. |
| 01/26/2034 | Expiration date for employee stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.